Silver Book Fact

The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.

Murphy K, Topel R. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003. https://press.uchicago.edu/ucp/books/book/chicago/M/bo3643529.html

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy K, Topel R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Increased Use of Medicines Reduces Risk of Death After Major Cardiovascular Events: Disease management program increased use of medicines  
  • Every year, around 250,000 Americans have an automatic intracardiac defibrillator (ICD) implanted. Data from clinical trials that compares ICDs to antiarrhythmic drugs show that the ICDs reduce sudden cardiac death…  
  • Assuming that Medicare Part D covers about 37% of beneficiaries’ drug costs, it is estimated that providing post-myocardial infarction Medicare beneficiaries with full coverage for combination pharmcotherapy will save more…  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Cost-savings associated with optimal anticoagulation in AFib patients
    If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct…